JP2014513929A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014513929A5 JP2014513929A5 JP2013557932A JP2013557932A JP2014513929A5 JP 2014513929 A5 JP2014513929 A5 JP 2014513929A5 JP 2013557932 A JP2013557932 A JP 2013557932A JP 2013557932 A JP2013557932 A JP 2013557932A JP 2014513929 A5 JP2014513929 A5 JP 2014513929A5
- Authority
- JP
- Japan
- Prior art keywords
- aptamer
- toxin
- difficile
- group
- assay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091023037 Aptamer Proteins 0.000 claims 38
- 241000193163 Clostridioides difficile Species 0.000 claims 13
- 101710084578 Short neurotoxin 1 Proteins 0.000 claims 8
- 101710182223 Toxin B Proteins 0.000 claims 8
- 101710182532 Toxin a Proteins 0.000 claims 8
- 238000003556 assay Methods 0.000 claims 8
- 238000000034 method Methods 0.000 claims 7
- 239000012634 fragment Substances 0.000 claims 6
- 230000004048 modification Effects 0.000 claims 6
- 238000012986 modification Methods 0.000 claims 6
- 238000006467 substitution reaction Methods 0.000 claims 4
- 239000003053 toxin Substances 0.000 claims 4
- 231100000765 toxin Toxicity 0.000 claims 4
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 3
- 238000007385 chemical modification Methods 0.000 claims 3
- 238000002944 PCR assay Methods 0.000 claims 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 238000010379 pull-down assay Methods 0.000 claims 2
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical group OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims 1
- LVYUDSCQJGQXBI-UHFFFAOYSA-N 2-naphthalen-2-ylacetamide Chemical compound C1=CC=CC2=CC(CC(=O)N)=CC=C21 LVYUDSCQJGQXBI-UHFFFAOYSA-N 0.000 claims 1
- LSBDFXRDZJMBSC-UHFFFAOYSA-N 2-phenylacetamide Chemical compound NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 claims 1
- KISUPFXQEHWGAR-RRKCRQDMSA-N 4-amino-5-bromo-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one Chemical group C1=C(Br)C(N)=NC(=O)N1[C@@H]1O[C@H](CO)[C@@H](O)C1 KISUPFXQEHWGAR-RRKCRQDMSA-N 0.000 claims 1
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 claims 1
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical group BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 claims 1
- WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims 1
- 150000001412 amines Chemical group 0.000 claims 1
- 229950004398 broxuridine Drugs 0.000 claims 1
- 229940104302 cytosine Drugs 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 230000011987 methylation Effects 0.000 claims 1
- 238000007069 methylation reaction Methods 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161451227P | 2011-03-10 | 2011-03-10 | |
| US61/451,227 | 2011-03-10 | ||
| PCT/US2012/028632 WO2012122540A1 (en) | 2011-03-10 | 2012-03-09 | Aptamers for clostridium difficile diagnostics |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014513929A JP2014513929A (ja) | 2014-06-19 |
| JP2014513929A5 true JP2014513929A5 (enExample) | 2015-03-12 |
| JP6018096B2 JP6018096B2 (ja) | 2016-11-02 |
Family
ID=46795908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013557932A Expired - Fee Related JP6018096B2 (ja) | 2011-03-10 | 2012-03-09 | クロストリジウム・ディフィシレ診断法のためのアプタマー |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8895241B2 (enExample) |
| EP (1) | EP2683729B1 (enExample) |
| JP (1) | JP6018096B2 (enExample) |
| KR (1) | KR20140015455A (enExample) |
| AU (2) | AU2012225273B2 (enExample) |
| CA (1) | CA2828286C (enExample) |
| ES (1) | ES2629183T3 (enExample) |
| WO (1) | WO2012122540A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2629183T3 (es) | 2011-03-10 | 2017-08-07 | Somalogic, Inc. | Aptámeros para diagnóstico de Clostridium difficile |
| CA2924987C (en) * | 2013-09-24 | 2022-08-16 | Somalogic, Inc. | Multiaptamer target detection |
| US10093933B2 (en) | 2014-02-18 | 2018-10-09 | Somalogic, Inc. | Compositions and methods for detecting microorganisms |
| NO2718257T3 (enExample) * | 2014-05-30 | 2018-04-14 | ||
| ES3013534T3 (en) * | 2016-07-01 | 2025-04-14 | Somalogic Operating Co Inc | Oligonucleotides comprising modified nucleosides |
| CN106841603B (zh) * | 2017-01-23 | 2020-11-06 | 郑州轻工业学院 | 一种利用血糖仪高灵敏定量检测黄曲霉毒素b1的方法 |
| WO2019103131A1 (ja) * | 2017-11-24 | 2019-05-31 | 国立大学法人 東京大学 | アプタマーの結合部位判別方法、アプタマーペアおよび目的物質からなる三元錯体の解離定数等の測定方法並びに最適なアプタマーペアの選択方法 |
| CN109507423A (zh) * | 2018-12-27 | 2019-03-22 | 南京祥中生物科技有限公司 | 一种基于适配体探针同时检测α-乳白蛋白、β-乳球蛋白和乳铁蛋白含量的方法 |
| JP2022535131A (ja) | 2019-06-05 | 2022-08-04 | リブ・プロセス・インコーポレイテッド | クロストリジウム・ディフィシル菌に対するアプタマー |
| KR102113078B1 (ko) * | 2019-07-05 | 2020-05-20 | 광주과학기술원 | 압타머의 선별 방법 |
| US11898146B2 (en) | 2020-12-03 | 2024-02-13 | Liv Process, Inc. | Aptamers against Clostridium difficile, compositions comprising aptamers against Clostridium difficile and methods of using the same |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070071744A1 (en) | 2002-06-07 | 2007-03-29 | Gotz Munch | Agents which bind to epitopes of glycoprotein VI |
| US7595160B2 (en) * | 2004-01-13 | 2009-09-29 | U.S. Genomics, Inc. | Analyte detection using barcoded polymers |
| US20100035247A1 (en) * | 2005-11-04 | 2010-02-11 | U.S. Genomics, Inc. | Heterogeneous Assay of Analytes in Solution Using Polymers |
| US8658670B2 (en) | 2006-09-26 | 2014-02-25 | Crestone, Inc. | Methods and compounds for treatment of clostridium based infection |
| US7964356B2 (en) * | 2007-01-16 | 2011-06-21 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| US7947447B2 (en) * | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| WO2009037264A2 (en) * | 2007-09-17 | 2009-03-26 | Da Volterra | Colonic delivery of antimicrobial agents |
| US8569252B2 (en) | 2009-04-15 | 2013-10-29 | Postech Academy-Industry Foundation | Nucleolin specific aptamer and use thereof |
| BRPI1011269A2 (pt) * | 2009-05-05 | 2016-09-27 | Altermune Technologies Llc | imunidade quimicamente programável |
| US20110256535A1 (en) * | 2010-02-11 | 2011-10-20 | Intelligent Medical Devices, Inc. | Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantification, monitoring, screening and sequencing of clostridium difficile genes encoding toxin b, and/or toxin a and/or binary toxin |
| GB201002627D0 (en) * | 2010-02-16 | 2010-03-31 | Loxbridge Res Llp | Aptamer based analyte detection method |
| US8785132B2 (en) | 2010-04-23 | 2014-07-22 | Postech Academy-Industry Foundation | Aptamer sandwich assays |
| ES2629183T3 (es) | 2011-03-10 | 2017-08-07 | Somalogic, Inc. | Aptámeros para diagnóstico de Clostridium difficile |
| SG10201607331WA (en) | 2011-09-30 | 2016-11-29 | Somalogic Inc | Cardiovascular risk event prediction and uses thereof |
-
2012
- 2012-03-09 ES ES12754934.3T patent/ES2629183T3/es active Active
- 2012-03-09 WO PCT/US2012/028632 patent/WO2012122540A1/en not_active Ceased
- 2012-03-09 AU AU2012225273A patent/AU2012225273B2/en not_active Ceased
- 2012-03-09 EP EP12754934.3A patent/EP2683729B1/en not_active Not-in-force
- 2012-03-09 US US13/417,035 patent/US8895241B2/en not_active Expired - Fee Related
- 2012-03-09 JP JP2013557932A patent/JP6018096B2/ja not_active Expired - Fee Related
- 2012-03-09 KR KR20137026658A patent/KR20140015455A/ko not_active Abandoned
- 2012-03-09 CA CA2828286A patent/CA2828286C/en not_active Expired - Fee Related
-
2014
- 2014-09-29 US US14/500,632 patent/US9081010B2/en active Active
-
2016
- 2016-11-14 AU AU2016256840A patent/AU2016256840B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014513929A5 (enExample) | ||
| US9926566B2 (en) | Multiaptamer target detection | |
| JP2014534207A5 (enExample) | ||
| US8895241B2 (en) | Aptamers for clostridium difficile diagnostics | |
| Pinto et al. | Label-free detection of gliadin food allergen mediated by real-time apta-PCR | |
| WO2012019187A3 (en) | Ligation-based detection of genetic variants | |
| KR101319202B1 (ko) | ｐＬＤＨ에 특이적으로 결합하는 ＤＮＡ 압타머 | |
| US10620210B2 (en) | Aptamers and diagnostic methods for detecting the EGF receptor | |
| Fu et al. | Enzyme linked aptamer assay: based on a competition format for sensitive detection of antibodies to Mycoplasma bovis in serum | |
| Zhang et al. | The bacterial enhancer-dependent RNA polymerase | |
| CA2939999A1 (en) | Compositions and methods for detecting microorganisms | |
| Yeoh et al. | Isolation of a novel DNA aptamer against LipL32 as a potential diagnostic agent for the detection of pathogenic Leptospira | |
| WO2006135527A3 (en) | Methods for the selection of aptamers | |
| WO2012038827A3 (en) | Genes linking several complications of type-2 diabetes (t2d) | |
| WO2006012468A3 (en) | Detection of oligonuleotides by dual hybridization | |
| US20180292404A1 (en) | Escherichia coli o157:h7 aptamer and applications thereof | |
| JP2004065264A5 (enExample) | ||
| Fooladi et al. | Applications and modifications of aptamers: potential tool for medical microbiology | |
| WO2018102115A1 (en) | Methods and systems for identifying candidate nucleic acid agent | |
| EP2811035A3 (en) | Compositions for detecting alicyclobacillus microorganisms | |
| Li et al. | Two distantly homologous DnaG primases from Thermoanaerobacter tengcongensis exhibit distinct initiation specificities and priming activities | |
| Class et al. | Patent application title: Multiaptamer Target Detection Inventors: Urs A. Ochsner (Denver, CO, US) Louis S. Green (Lafayette, CO, US) Larry Gold (Boulder, CO, US) Nebojsa Janjic (Boulder, CO, US) Nebojsa Janjic (Boulder, CO, US) Evaldas Katilius (Superior, AZ, US) | |
| Price | How To Turn On A Riboswitch: Structural And Mechanistic Lessons Learned From S-Adenosyl-L-Methionine-And Manganese-Sensing Rnas | |
| JP2010142235A5 (enExample) | ||
| WO2006073587A3 (en) | Hemipteran 5-hydroxytryptamine 7 serotonin receptor |